Ghent University Academic Bibliography

Advanced

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire

Julie Devos UGent, Charles Van Praet UGent, Karel Decaestecker UGent, Tom Claeys, VALERIE FONTEYNE, Veerle Decalf UGent, Gert De Meerleer UGent, Piet Ost UGent and Nicolaas Lumen UGent (2015) ACTA CLINICA BELGICA. 70(4). p.272-279
abstract
Background: Men diagnosed with localised prostate cancer (PC) have to make a well-informed treatment choice between (robot-assisted) radical prostatectomy (RARP), external beam radiotherapy (EBRT) and, in selected cases, brachytherapy and active surveillance. We developed and validated a questionnaire to determine the cognitive reasons why patients choose their treatment. Materials and methods: The Prostate Cancer Decision-Making Questionnaire (PC-DMQ) was designed in-house and validated through the Delphi method by seven external experts. Finally, we tested this questionnaire in a cohort of 24 men, recently diagnosed with localised PC, before undergoing RARP (n = 16), EBRT (n = 6), brachytherapy (n = 1) or active surveillance (n = 1). Results: The experts reached consensus after three discussion rounds. In the patient cohort, 75% of men undergoing RARP chose this treatment because ‘it provides the best chance of cure’. Reasons to choose EBRT were not as explicit: 33.3% chose this treatment because ‘it provides the best chance of cure’ and 33.3% because ‘the maintenance of potency is important to them’. Conclusions: The PC-DMQ is a comprehensive and standardised tool that allows further research into cognitive factors that influence treatment decision-making in patients with localised PC.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
Treatment decision making, Localised prostate cancer, Treatment choice, Prostatic neoplasms, MEN, RISK, UPDATE, ANTIGEN, RADIOTHERAPY, RADICAL PROSTATECTOMY, RADIATION-THERAPY, DIAGNOSIS
journal title
ACTA CLINICA BELGICA
Acta Clin. Belg.
volume
70
issue
4
pages
272 - 279
Web of Science type
Article
Web of Science id
000359981200006
ISSN
2295-3337
DOI
10.1179/2295333715Y.0000000015
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
6862936
handle
http://hdl.handle.net/1854/LU-6862936
date created
2015-07-03 17:36:16
date last changed
2016-12-19 15:38:56
@article{6862936,
  abstract     = {Background: Men diagnosed with localised prostate cancer (PC) have to make a well-informed treatment choice between (robot-assisted) radical prostatectomy (RARP), external beam radiotherapy (EBRT) and, in selected cases, brachytherapy and active surveillance. We developed and validated a questionnaire to determine the cognitive reasons why patients choose their treatment.
Materials and methods: The Prostate Cancer Decision-Making Questionnaire (PC-DMQ) was designed in-house and validated through the Delphi method by seven external experts. Finally, we tested this questionnaire in a cohort of 24 men, recently diagnosed with localised PC, before undergoing RARP (n\,=\,16), EBRT (n\,=\,6), brachytherapy (n\,=\,1) or active surveillance (n\,=\,1).
Results: The experts reached consensus after three discussion rounds. In the patient cohort, 75\% of men undergoing RARP chose this treatment because {\textquoteleft}it provides the best chance of cure{\textquoteright}. Reasons to choose EBRT were not as explicit: 33.3\% chose this treatment because {\textquoteleft}it provides the best chance of cure{\textquoteright} and 33.3\% because {\textquoteleft}the maintenance of potency is important to them{\textquoteright}.
Conclusions: The PC-DMQ is a comprehensive and standardised tool that allows further research into cognitive factors that influence treatment decision-making in patients with localised PC.},
  author       = {Devos, Julie and Van Praet, Charles and Decaestecker, Karel and Claeys, Tom and FONTEYNE, VALERIE and Decalf, Veerle and De Meerleer, Gert and Ost, Piet and Lumen, Nicolaas},
  issn         = {2295-3337},
  journal      = {ACTA CLINICA BELGICA},
  keyword      = {Treatment decision making,Localised prostate cancer,Treatment choice,Prostatic neoplasms,MEN,RISK,UPDATE,ANTIGEN,RADIOTHERAPY,RADICAL PROSTATECTOMY,RADIATION-THERAPY,DIAGNOSIS},
  language     = {eng},
  number       = {4},
  pages        = {272--279},
  title        = {Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire},
  url          = {http://dx.doi.org/10.1179/2295333715Y.0000000015},
  volume       = {70},
  year         = {2015},
}

Chicago
Devos, Julie, Charles Van Praet, Karel Decaestecker, Tom Claeys, Valérie Fonteyne, Veerle Decalf, Gert De Meerleer, Piet Ost, and Nicolaas Lumen. 2015. “Cognitive Factors Influencing Treatment Decision-making in Patients with Localised Prostate Cancer: Development of a Standardised Questionnaire.” Acta Clinica Belgica 70 (4): 272–279.
APA
Devos, Julie, Van Praet, C., Decaestecker, K., Claeys, T., Fonteyne, V., Decalf, V., De Meerleer, G., et al. (2015). Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire. ACTA CLINICA BELGICA, 70(4), 272–279.
Vancouver
1.
Devos J, Van Praet C, Decaestecker K, Claeys T, Fonteyne V, Decalf V, et al. Cognitive factors influencing treatment decision-making in patients with localised prostate cancer: development of a standardised questionnaire. ACTA CLINICA BELGICA. 2015;70(4):272–9.
MLA
Devos, Julie, Charles Van Praet, Karel Decaestecker, et al. “Cognitive Factors Influencing Treatment Decision-making in Patients with Localised Prostate Cancer: Development of a Standardised Questionnaire.” ACTA CLINICA BELGICA 70.4 (2015): 272–279. Print.